157 related articles for article (PubMed ID: 2891368)
1. Non-invasive instrumental techniques to detect terfenadine and temelastine induced suppression of histamine weals in man.
Shall L; Marks R
Br J Clin Pharmacol; 1987 Oct; 24(4):409-13. PubMed ID: 2891368
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the duration of action of terfenadine on histamine induced weals.
Shall L; Newcombe RG; Marks R
Br J Dermatol; 1988 Oct; 119(4):525-31. PubMed ID: 3142511
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
Shall L; Newcombe RG; Lush M; Marks R
Acta Derm Venereol; 1991; 71(3):199-204. PubMed ID: 1678220
[TBL] [Abstract][Full Text] [Related]
4. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
Van Neste D; Rihoux JP
Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
[TBL] [Abstract][Full Text] [Related]
6. Quantitative time course study of the skin response to histamine and the effect of H1 blockers. A 3-week crossover double-blind comparative trial of cetirizine and terfenadine.
Rihoux JP; Van Neste DJ
Dermatologica; 1989; 179(3):129-34. PubMed ID: 2574115
[TBL] [Abstract][Full Text] [Related]
7. Effects of cetirizine, loratadine and terfenadine on histamine weal and flare reactions.
Lever LR; Hill S; Marks R; Rosenberg R; Thompson D
Skin Pharmacol; 1992; 5(1):29-33. PubMed ID: 1533530
[TBL] [Abstract][Full Text] [Related]
8. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
9. Temelastine, a new H1-receptor antagonist.
Alexander F; Stote RM; Allison N; Familiar RG; Tatoian D; Dubb JW
J Int Med Res; 1986; 14(4):200-4. PubMed ID: 2875907
[TBL] [Abstract][Full Text] [Related]
10. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
11. Antihistaminic activity and side effect profile of epinastine and terfenadine in healthy volunteers.
Schilling JC; Adamus WS; Kuthan H
Int J Clin Pharmacol Ther Toxicol; 1990 Dec; 28(12):493-7. PubMed ID: 1982280
[TBL] [Abstract][Full Text] [Related]
12. The role of histamine in the acute inflammatory responses to intradermal platelet activating factor.
Sciberras DG; Jordan S; Gill D; Baber NS; James I
Br J Clin Pharmacol; 1991 Jul; 32(1):85-90. PubMed ID: 1679658
[TBL] [Abstract][Full Text] [Related]
13. Lack of subsensitivity to terfenadine during long-term terfenadine treatment.
Simons FE; Watson WT; Simons KJ
J Allergy Clin Immunol; 1988 Dec; 82(6):1068-75. PubMed ID: 2904930
[TBL] [Abstract][Full Text] [Related]
14. Blood flow in histamine- and allergen-induced weal and flare responses, effects of an H1 antagonist, alpha-adrenoceptor agonist and a topical glucocorticoid.
Hammarlund A; Olsson P; Pipkorn U
Allergy; 1990 Jan; 45(1):64-70. PubMed ID: 2137995
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin induced wheal and flare is not mediated by histamine release or cyclooxygenase products.
Crossman DC; Fuller RW
Br J Clin Pharmacol; 1988 Jul; 26(1):113-5. PubMed ID: 2462442
[TBL] [Abstract][Full Text] [Related]
16. Potent vasoactive properties of endothelin 1 in human skin.
Crossman DC; Brain SD; Fuller RW
J Appl Physiol (1985); 1991 Jan; 70(1):260-6. PubMed ID: 1707048
[TBL] [Abstract][Full Text] [Related]
17. The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin.
Kavanagh GM; Sabroe RA; Greaves MW; Archer CB
Br J Dermatol; 1998 Apr; 138(4):622-6. PubMed ID: 9640366
[TBL] [Abstract][Full Text] [Related]
18. Start and end of the effects of terfenadine and astemizole on histamine-induced wheals in human skin.
Työlahti H; Lahti A
Acta Derm Venereol; 1989; 69(3):269-71. PubMed ID: 2566243
[TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo controlled dose response study of noberastine on histamine induced weal and flare.
Kamali F; Emanuel M; Rawlins MD
Eur J Clin Pharmacol; 1991; 40(1):83-5. PubMed ID: 1676366
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of cutaneous reactivity to histamine: a double-blind acute comparative study between cetirizine, terfenadine and astemizole.
Ghys L; Rihoux JP
J Int Med Res; 1989; 17(1):24-7. PubMed ID: 2565265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
